Related Experiment Videos
Incipient analysis of mesenchymal stem-cell-derived osteogenesis.
L F Cooper1, C T Harris, S P Bruder
11 Dental Research Center, University of North Carolina School of Dentistry, Chapel Hill, 27559-7450, USA. Lyndon_Cooper@Dentistry.unc.edu
Journal of Dental Research
|March 28, 2001
Summary
Bone sialoprotein (BSP) expression in mesenchymal stem cell (MSC) implants indicates early bone formation. This finding aids in assessing osteogenesis in cell-based tissue regeneration therapies.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Stem Cell Biology
Background:
- Cell-based therapies are crucial for effective tissue regeneration.
- Assessing mesenchymal stem cell (MSC)-directed bone regeneration currently relies on histology.
- A need exists for early indicators of osteogenesis in MSC implants.
Purpose of the Study:
- To investigate the relationship between bone sialoprotein (BSP) and osteocalcin expression and osteogenesis in MSC implants.
- To determine if BSP gene expression can serve as an early marker for bone formation.
Main Methods:
- RT-PCR was used to assess gene expression (human actin, collagen type I, BSP, osteocalcin) in undifferentiated MSCs.
- Human BSP expression was analyzed in RNAs isolated from MSC implants retrieved at 3 weeks post-implantation in SCID mice.
- Histologic assessment of bone formation was performed on parallel implants harvested at 6 weeks.
Main Results:
- Undifferentiated MSCs did not express BSP or osteocalcin.
- Human BSP was detected in RNAs from implants at 3 weeks.
- All implants positive for human BSP at 3 weeks showed histologic evidence of bone formation at 6 weeks.
Conclusions:
- Culture-expanded, cryopreserved human MSCs demonstrate osteogenic potential in the SCID mouse model.
- Implanted cell gene expression, specifically BSP, can predict early bone formation.
- BSP expression serves as a reliable early indicator of osteogenesis in MSC-based bone regeneration.